IRIS
AMADORI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.826
AS - Asia 38
SA - Sud America 4
Totale 1.868
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.824
CN - Cina 32
BR - Brasile 3
SG - Singapore 3
FI - Finlandia 2
VN - Vietnam 2
AR - Argentina 1
BH - Bahrain 1
Totale 1.868
Salva come PNG Salva come JPEG
Città #
Genoa 1.172
Vado Ligure 232
Genova 211
Rapallo 196
Beijing 15
Bordighera 9
Hanoi 2
Lappeenranta 2
Santa Teresa di Riva 2
Concepción 1
Guanambi 1
Manama 1
Milan 1
Minas Novas 1
Singapore 1
São Paulo 1
Totale 1.848
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and genotype-phenotype correlations in PRRT2 Italian patients 126
Emerging treatments for progressive myoclonus epilepsies 107
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants 101
A further contribution to the delineation of epileptic phenotype in PACS2-related syndrome 96
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 95
Abnormal circadian rhythm in patients with GRIN1-related developmental epileptic encephalopathy 88
Epilepsy Course and Developmental Trajectories in STXBP1-DEE 85
Acute Neurological Presentation in Children With SARS-CoV-2 Infection 70
Exploring treatments for drooling in children with neurological disorders 70
Abnormal course of the corticospinal tracts in KIF5C-related encephalopathy 68
Epilepsy features in ARID1B-related Coffin-Siris syndrome 64
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 61
New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment 60
Impact and management of drooling in children with neurological disorders: an Italian Delphi consensus 59
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 56
Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: The Italian experience from the 'beyond epilepsy' project 53
Current and promising therapeutic options for Dravet syndrome 53
Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients 50
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals 50
Epileptic encephalopathy caused by ARV1 deficiency: Refinement of the genotype–phenotype spectrum and functional impact on GPI-anchored proteins 50
Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overview 47
Electroclinical Features of Epilepsy in Kleefstra Syndrome 45
Pediatric SARS-CoV-2-Related Diplopia and Mesencephalic Abnormalities 45
Neuromuscular and Neuroendocrinological Features Associated With ZC4H2-Related Arthrogryposis Multiplex Congenita in a Sicilian Family: A Case Report 43
Case Report: Novel biallelic moderately damaging variants in RTTN in a patient with cerebellar dysplasia 40
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 32
Neonatal Perforator Stroke: Timing, Risk Factors, and Neurological Outcome from a Single-Center Experience 32
Precision medicine in early-onset epilepsy: The KCNQ2 paradigm 31
Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy 30
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 28
Answer to: Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy (Amadori E et al., 2022). EJMG-D-22-00384 27
Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation 21
Genome-wide association meta-analyses of drug-resistant epilepsy 15
Medication-resistant epilepsy is associated with a unique gut microbiota signature 9
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data 1
Totale 1.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.553
article - articoli 9.553
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 57 3 2 2 14 9 17 8 7
2021/2022102 3 2 2 1 2 7 1 21 4 24 9 26
2022/2023233 18 17 5 21 44 34 0 21 29 1 36 7
2023/2024245 11 18 17 32 15 44 14 18 8 9 27 32
2024/2025768 32 45 16 51 51 69 62 165 43 51 104 79
2025/2026437 174 26 113 124 0 0 0 0 0 0 0 0
Totale 1.908